| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 05/03/2007 | WO2007049749A1 Therapeutic method for blood coagulation disorder |
| 05/03/2007 | WO2007049726A1 Biodegradable particle and method for producing the same |
| 05/03/2007 | WO2007049628A1 Blood flowability-improving agent |
| 05/03/2007 | WO2007049587A1 Enteric-coated preparation |
| 05/03/2007 | WO2007049553A1 Agent for treatment of circulatory failure |
| 05/03/2007 | WO2007002571A3 Use of an anti c5 complement antibody to treat patients with sickle cell disease |
| 05/03/2007 | WO2006138534A3 Stable warfarin sodium liquid formulation and method of making same |
| 05/03/2007 | US20070100133 Erythropoietic compounds |
| 05/03/2007 | US20070099981 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 05/03/2007 | US20070099980 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 05/03/2007 | US20070099927 Aminoalkyl-pyrazinones and-pyridones as thrombin inhibitors |
| 05/03/2007 | US20070099921 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/03/2007 | US20070099899 Heterocyclic dihydropyrimidine compounds |
| 05/03/2007 | US20070098777 Pharmaceutical or Food Composition for Treatment or Prevention of Brain Edema |
| 05/03/2007 | US20070098757 E-PTFE foil impregnated with an encapsulated bioactive substance |
| 05/03/2007 | US20070098732 Immunologic compounds for prevention, protection, prophylaxis or treatment of immunological disorders, infections and cancer |
| 05/03/2007 | US20070098724 Methods of Treatment Using Vascular Occlusion in Combination with One or More Therapies |
| 05/03/2007 | CA2627640A1 Therapeutic drug for suppressing functions of nkt cells containing glycolipid derivative as active ingredient |
| 05/03/2007 | CA2627478A1 Therapeutic method for blood coagulation disorder |
| 05/03/2007 | CA2627303A1 Agent for treatment of circulatory failure |
| 05/03/2007 | CA2626881A1 Biodegradable particle and production method thereof |
| 05/02/2007 | EP1779865A1 Use of human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells |
| 05/02/2007 | EP1778677A1 Heterocyclic condensed compounds useful as antidiuretic agents |
| 05/02/2007 | EP1778247A1 Pharmaceutical combinations containing an inhibitor of platelet aggregation and a fibrate |
| 05/02/2007 | EP1608645B1 Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses |
| 05/02/2007 | EP1441723B1 Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension |
| 05/02/2007 | EP1418905B1 Therapeutic agent for depletion of an unwanted protein population from plasma |
| 05/02/2007 | EP1408952B1 Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders |
| 05/02/2007 | EP1395606B1 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
| 05/02/2007 | EP1313716B1 Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists |
| 05/02/2007 | EP1104323A4 Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby |
| 05/02/2007 | EP1077721B1 Prevention and treatment of hypergastrinemia |
| 05/02/2007 | CN1957082A Novel galectin 9 modification protein and use thereof |
| 05/02/2007 | CN1955192A Protein for promoting erythrocyte growth factor activity and its use |
| 05/02/2007 | CN1955151A Alpha-bulnesene, its preparation and its use |
| 05/02/2007 | CN1954825A Supermicro Tongxinluo Chinese herbal composite and its new usage |
| 05/02/2007 | CN1954818A Application of phillyrin in preparation for treating endotoxemia |
| 05/02/2007 | CN1954812A Use of Edaravone |
| 05/02/2007 | CN1313493C Method of producing human albumin involving heating step |
| 05/02/2007 | CN1313450C Tachykinin receptor antagonists |
| 05/02/2007 | CN1313448C Metalloproteinase inhibitors |
| 05/02/2007 | CN1313088C Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders |
| 05/01/2007 | US7211694 Substituted 4-aminocyclohexanols |
| 05/01/2007 | US7211662 Soluble highly branched glucose polymers and their method of production |
| 05/01/2007 | US7211656 Using the enzymes to make polyunsaturated fatty acids; added to pharmaceutical compositions, nutritional compositions, animal feeds, cosmetics |
| 05/01/2007 | US7211648 Gag-peptide complex |
| 05/01/2007 | US7211601 Prevention labor contraction; urogenital disorders |
| 05/01/2007 | US7211598 Oxime and/or hydrozone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 05/01/2007 | US7211578 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with TNF activity |
| 05/01/2007 | US7211563 For use in diagnosis, study, prophylaxis, and therapy of diseases and disorders related to body-weight regulation, metabolic diseases such as obesity, as well as related disorders such as adipositas, eating disorders, cachexia |
| 05/01/2007 | US7211560 Hemoglobulin for oxygen delivery; cardiovascular disorders; gastrointestinal disorders |
| 05/01/2007 | US7211258 Protein A compositions and methods of use |
| 05/01/2007 | US7211253 Erythropoietin forms with improved properties |
| 05/01/2007 | CA2320706C 20-hete antagonists and agonists |
| 05/01/2007 | CA2206748C Salts of ethyl 3-(2-(4-(4-(amino-imino-methyl)phenyl)-4-methyl-2,5-dioxoimidazolidin-1-yl)acetylamino)-3-phenylpropionate |
| 05/01/2007 | CA2188267C Use of tetrahydropteridine derivatives as no-synthase inhibitors |
| 05/01/2007 | CA2185394C Biotinderivate |
| 04/26/2007 | WO2007046127A1 Platelet aggregation inhibitor and health food effective in inhibiting platelet aggregation |
| 04/26/2007 | WO2007045339A1 Imidazole derivatives as inhibitors of tafia |
| 04/26/2007 | WO2006108039A3 Substituted azetidinones |
| 04/26/2007 | WO2006042724A3 Magnetic particles for therapy and diagnosis |
| 04/26/2007 | US20070093472 1-[(4-Ethynylphenyl)]-2-[(phenyl)]-pyrrolidine-1,2-dicarboxamide derivatives as inhibitors of coagulation factors xa and viia for the treatment of thromboses |
| 04/26/2007 | US20070092948 DNA segment encoding the enzyme inhibitor for therapy of thrombosis, blood disorders; biodrugs; genetic vaccines; monoclonal antibodies; host cells |
| 04/26/2007 | CA2622397A1 Platelet aggregation inhibitor and health food effective in inhibiting platelet aggregation |
| 04/25/2007 | EP1776956A1 Preventive and/or therapeutic agent for calcipenia |
| 04/25/2007 | EP1776954A2 The use of inhibitors of the renin-angiotensin system for the treatment of stroke |
| 04/25/2007 | EP1776159A1 Food products for diabetics |
| 04/25/2007 | EP1776138A1 tRNA SYNTHETASE FRAGMENTS |
| 04/25/2007 | EP1776108A1 Enoximone formulations and their use in the treatment of pde-iii mediated diseases |
| 04/25/2007 | EP1425042B1 Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c5b |
| 04/25/2007 | EP1421120B1 Hyperbranched amylopectin for use in methods for surgical or therapeutic treatment of mammals or in diagnostic methods, especially for use as a plasma volume expander |
| 04/25/2007 | EP1408950B1 Methods of treating cytokine mediated diseases |
| 04/25/2007 | EP1401449B1 Tetracyclic compounds as pde5-inhibitors |
| 04/25/2007 | EP1337267B1 Use of blood coagulation factor xiii for treating haemophilia a |
| 04/25/2007 | EP1305294B1 Imidazolyl derivatives |
| 04/25/2007 | CN1953738A Effervescent formulations comprising desmopressin |
| 04/25/2007 | CN1952123A Method for improving expression efficiency of lumbru kinase component F-III in yeast |
| 04/25/2007 | CN1951939A Novel pyrrole derivatives as pharmaceutical agents |
| 04/25/2007 | CN1951504A Zinc finger protein HZF1 gene function and application thereof |
| 04/25/2007 | CN1951493A Chinese medicinal preparation for treating apoplexy sequelae |
| 04/25/2007 | CN1951491A Method for preparing blood replenishing capsule 'Wei Xue Kang' |
| 04/25/2007 | CN1951481A Medicament for treating cerebral thrombosis |
| 04/25/2007 | CN1951479A Medicament for treating thrombocytopenia |
| 04/25/2007 | CN1951474A A Chinese medicinal injection and preparation method thereof |
| 04/25/2007 | CN1951473A Quality control method of a Chinese medicinal injection |
| 04/25/2007 | CN1951451A Method for supercritical extraction of active ingredient of camellia |
| 04/25/2007 | CN1951449A Medicament for increasing peripheral blood leukocyte and use thereof |
| 04/25/2007 | CN1951431A Quality control method of a pharmaceutical composition |
| 04/25/2007 | CN1951427A Quality control method of a pharmaceutical composition |
| 04/25/2007 | CN1951426A Quality control method of a compound Chinese medicinal preparation |
| 04/25/2007 | CN1951416A Quality control method of a compound Chinese medicinal preparation |
| 04/25/2007 | CN1951404A Oral microemulsion of gingko leaf and preparation method thereof |
| 04/25/2007 | CN1951393A Hydrophobic formulation containing total notoginseng glycosides and phospholipid and preparation method thereof |
| 04/25/2007 | CN1951381A Baicalin solution composition |
| 04/25/2007 | CN1951371A Immediate release tablet |
| 04/25/2007 | CN1951199A Coarse cereal powder for treating anaemia |
| 04/25/2007 | CN1312183C Heparinase I fusion protein and genes encoding same and expression method thereof |
| 04/25/2007 | CN1312181C Human monoclonal antibodies to FC Alpha receptor (CD89) |
| 04/25/2007 | CN1312176C Buthotoxin polypeptide and preparation method thereof |
| 04/25/2007 | CN1312120C Adamantane derivatives |